Pancreatic cancer (also called cancer of the pancreas) is represented by the growth of a malignant tumour within the small pancreas organ. Each year about 31,000 individuals in the United States are diagnosed with this condition, with more than 60,000 in Europe.
Pancreatic cancer risk decreased by one anti-diabetic therapy, increased by others – The antidiabetic medication metformin is associated with a reduced risk of pancreatic cancer in diabetics, revealed by researchers. However, other commonly used therapies, such as insulin or insulin secretagogues, may be associated with increased risk.
Dietary fat linked to pancreatic cancer — researchers observed positive associations between pancreatic cancer and intakes of total, saturated, and monounsaturated fat overall, particularly from red meat and dairy food sources. – High intake of dietary fats from red meat and dairy products was associated with an increased risk of pancreatic cancer, revealed by researchers. This study was undertaken because research relating fat intake to pancreatic cancer was inconclusive.
Being overweight, obese during early adulthood associated with greater risk of pancreatic cancer – Young adults who are overweight or obese have an increased risk of pancreatic cancer, and being obese at an older age is associated with a lower overall survival rate for patients with pancreatic cancer, revealed by researchers.
Markers for inflammation discovered in breast cancer survivors are linked to survival – A study led by researchers at Fred Hutchinson Cancer Research Center has identified two proteins in the blood that could become important prognostic markers for long-term survival in breast cancer patients.
GenWay Biotech obtains exclusive rights to AMDL’s DR-70 cancer test in US and Canada. AMDL Inc. executes two exclusive distribution agreements for cancer test with GenWay Biotech Inc. – GenWay Biotech, Inc., a US-based diagnostic company which specializes in providing protein and antibody solutions, announced its partnership with AMDL, Inc., a US-based pharmaceutical company with major operations in China, regarding the distribution of AMDL’s DR-70 (FDP) cancer test in both the United States and Canada.
Meat cooked at high temperatures and charring may increase the risk of pancreatic cancer, revealed by researchers. – Meat cooked at high temperatures to the point of burning and charring may increase the risk of pancreatic cancer, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009.
An herbal extract of Nigella sativa inhibits the development of pancreatic cancer due to thymoquinone, the major constituent of the oil extract. – Nigella sativa – an herb recently found to kill pancreatic cancer cells also appears to inhibit development of pancreatic cancer as a result of its anti-inflammatory properties, according to researchers from the Kimmel Cancer Center at Jefferson.
Early detection methods for pancreatic cancer urgently needed: a statement from the PANCREATIC CANCER ACTION NETWORK – The following is a statement in response to the breaking news about Supreme Court Justice Ruth Bader Ginsburg being diagnosed with pancreatic cancer from Julie Fleshman, President and CEO of the Pancreatic Cancer Action Network, the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure.
Abraxis BioScience Announces Plan to Create Abraxis Health, a New Enterprise Focused on Biomarkers and Personalized Medicine – Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, announced that the Board of Directors has approved a strategic plan to create Abraxis Health, Inc., an independent, stand-alone company to be spun-off from Abraxis BioScience that will be dedicated to becoming a fully integrated, next-generation, evidence-based, personalized healthcare company.
High-dose injections of vitamin C may reduce tumor weight and growth rate by about 50 percent of brain, ovarian, and pancreatic cancers, – High-dose injections of vitamin C, also known as ascorbate or ascorbic acid, reduced tumor weight and growth rate by about 50 percent in mouse models of brain, ovarian, and pancreatic cancers, researchers from the National Institutes of Health (NIH) report in the August 5, 2008, issue of the Proceedings of the National Academy of Sciences.
